MedLever

The automation platform for radiation oncology.

[ASTRO @ASTRO_org]

Today, ASTRO brought together leaders from industry and across the field for our inaugural AI Roundtable to discuss the evolving role of artificial intelligence in radiation oncology and patient care.

Thank you to Fuse Oncology, MedLever, Novartis, Siemens Healthineers and Merck for sponsoring this important conversation.

Learn more about ASTRO's AI initiatives
Rad Onc Report on AI: https://t.co/HsI8beL8cQ
Spring 2026 ASTROnews article: https://t.co/iLgwLtIFax

#RadOnc #AI @fuseoncology @MedLever @Novartis @SiemensHealth @Merck @NehaVapiwala

[Neha Vapiwala @NehaVapiwala]

@ASTRO_org is grateful to all who have shared their situation & continues to seek member feedback @ our dedicated Payer Support and Resolution Center resource page. 🙏🏽
https://t.co/5OqvfGOh0S

[Neha Vapiwala @NehaVapiwala]

Cancer’s impact transcends borders. Mission-driven @ASTRO_org members like @TamerRefaatMD are leading ASTRO’s charge to address #radiotherapy care access & quality on a global scale. His words are inspiring, but it’s his actions - alongside those of many other committed colleagues - that will move the needle. Come listen & learn how to get more involved!

[Daniel E Spratt @DrSpratticus]

**ANNOUNCEMENT**
Our growth continues with strategic expansions and our recruiting for FOUR (yes 4) new physicians to join our remarkable team!

Includes the Vice Chair of Research, Director of Brachytherapy, and two additional clinical-academic faculty positions

Read more...

@NicholasZaorsky @angela_jia_ @lauren_henke @Soum_Roy_RadOnc @HaleyPerlow @APrice_BeamOn @NRGonc @ACRORadOnc @ARRO_org @ASCO @IJROBP @RadOncUH @a_dalpra @AmarUKishan @HimanshuNagarMD @PCFnews @urotoday

[ASTRO @ASTRO_org]

ASTRO is deeply disturbed by the inaccurate, inappropriate, and irresponsible NBC News piece on IORT. We feel this story harms care for breast cancer patients & have strongly rebutted it through our Breast Cancer Resource Panel & a letter from ASTRO CEO, Vivek S Kavadi, MD to NBC News.

Read each here:
Breast Resource Panel Statement
https://t.co/KU1jDQJnaf

Letter to NBC News from Dr. Vivek S. Kavadi
https://t.co/FxfoEtGI7R

[ASTRO @ASTRO_org]

Missing #ASTRO25 already?
Watch ASTRO's 2025 Annual Meeting onDemand.

Access more than 200 hours of scientific and educational content from leading experts & claim 190+ AMA PRA Category 1™ CME credits. All available on the 2025 Annual Meeting Portal.

Learn more and purchase now: https://t.co/RbTllwS0AO

[David Sher @DavidSherMD]

Terrific thread by @seanmmcbride

While it is important to keep an open mind when faced with bizarre results, the raw survival numbers are almost incomprehensible.

In the ITT population:

- In the IMRT arm, there were 29 recurrences (Table 1) and 23 deaths due to cancer (Table S1).
- In the IMPT arm, there were 25 recurrences and 11 deaths due to cancer.
- Thus, 79% of IMRT recurrences led to cancer-specific mortality, versus only 44% of IMPT recurrences.

In the PP population:

- In the IMRT arm, there were 23 recurrences and 27 deaths (Fig 3b), of which 10 were without progression (Table 1). We don’t know further causes of death.
- In the IMPT arm, there were 23 recurrences and only 16 deaths, of which 9 were without progression.
- Thus, 74% (17/23) IMRT recurrent patients died, and only 30% (7/23) IMPT recurrent patients died.

These survival after salvage numbers aren’t just statistically significant, they are miraculous. To have 70% of R/M HNSCC alive after IMPT has to reflect something beyond biology.

I’m looking forward to the final publication and analysis, but there is a “know it when you see it" phenomenon with confounding, and that appears to hold here.

[MedLever @MedLever]

🚀 Instant Documentation, Zero Hassle

In just 2-5 minutes, you can complete clinical radiotherapy documentation and launch all care paths from a single interaction.

✅ Fast: Generate high-quality, customized documents instantly
✅ Smart: Automation ensures accuracy and consistency
✅ Seamless: Signed documents sync directly with your EMR

⚡ Work smarter, streamline documentation, and stay focused on patient care.

📍 https://t.co/Vi7bWyJace

[MedLever @MedLever]

🤝 True Partnership, Real Impact with MedLever

At MedLever, we understand the importance of true partnership.
When we collaborate with clinics, it's about creating workflows that work best for them. From the initial implementation to ongoing revisions, we're committed to optimizing the platform to fit each clinic's unique needs.

Our focus is on:
✨ Customization – Tailoring workflows to your specific processes
✨ Personalization – Adapting the platform to meet your goals
✨ Collaboration – Partnering with your team for continuous improvement

With MedLever, clinics gain a lifetime commitment to support and assistance—because patient outcomes come first.

[MedLever @MedLever]

As we look back and reflect on a year of growth, innovation, and collaboration. 2024's achievements have brought us closer to our mission of advancing patient care and operational excellence.

Thank you to our clients and partners for making this success possible—here’s to an even brighter 2025! 🌱

[MedLever @MedLever]

Thank you to @DrSpratticus,
@RaedZuhour, @angela_jia_ , and the team at University Hospitals for their leadership in advancing radiation oncology workflows. The comprehensive modeling of their processes was achieved with an impressive balance of standardization, customization, and flexibility, accommodating the unique needs of the patient, their physicians, and the clinical teams.

[Daniel E Spratt @DrSpratticus]

9/ Revolutionizing workflows with our end to end custom built learning health system for radonc with @MedLever.

Led by @RaedZuhour , our team built a learning radiation oncology EMR—fully automating orders, documentation, nursing tasks, billing, and physics workflows. Gets better and better every iteration.

[MedLever @MedLever]

@ParikhSimul @oncoramed @JordanJ65544091 We use Aria or MOSAIQ as the source of truth, so everything we generate ends up there.

We can work with your technical team to determine how that content gets into Epic at the encounter level.

[MedLever @MedLever]

@ParikhSimul @oncoramed @JordanJ65544091 We can auto generate all the needed documents, provide a medium for multi-department access and set up the tasks and notifications to clinical and revenue cycle team members.

[ASTRO @ASTRO_org]

We are one week away from the #ASTRO23 Annual Meeting & there is still time to register! Register today: https://t.co/Lk6g7bBQ1Q

[MedLever @MedLever]

Are you attending #ASTRO23? Come check us out at Booth 3523.

@medlever is the air-traffic control for your clinic and the digital assistant for your #radonc workflow.

See our automation engine simplify documentation and our electronic task-tracking whiteboards keep the whole department in sync. See you in San Diego!

[MedLever @MedLever]

Help your #radonc team spend less time on paperwork and more time on patient care. Register: https://t.co/Cg55Ol2dVR

#radonc #HealthcareInnovation #rpa #Automation

[MedLever @MedLever]

@RadOncUH @RaySearch @KashaniRojano @DrSpratticus Thank you for that shout-out, @RadOncUH and @DrSpratticus 😀
Interested in learning how the RadOncUH team is transforming their workflow using MedLever? Join us live for a webinar on 8/16 at 12pm PDT. Register: https://t.co/Cg55Ol2dVR

[MedLever @MedLever]

Register here: https://t.co/Cg55Ol2dVR

[RadOncUH @RadOncUH]

**HIRING @ UH Seidman Cancer Center's @RadOncUH**

Calling Medical Physicists- We are recruiting!

Excited to announce we have grown by >40% in past 2 yrs, and have 4 new LINACs soon to go live and innovative new software @MedLever @RaySearch

@KashaniRojano
@DrSpratticus